Pricing Log in Create free account

AnaptysBio, Inc. (ANAB) vs Immunocore Holdings PLC Sponsored ADR (IMCR)

AnaptysBio, Inc. and Immunocore Holdings PLC Sponsored ADR are both Biotechnology companies. AnaptysBio, Inc. and Immunocore Holdings PLC Sponsored ADR are of similar size ($1.5B and $1.5B). AnaptysBio, Inc. grew revenue faster over the last twelve months: 107.7% against 21.0%. Immunocore Holdings PLC Sponsored ADR has the higher net margin (−4.20% vs −11.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, AnaptysBio, Inc. leads on 9 and Immunocore Holdings PLC Sponsored ADR on 8.

Valuation

Metric ANAB IMCR Biotechnology median
P/E n/m n/m 8.50
P/S 5.75 3.48 9.71
P/B 104.91 3.57 2.13
Price to free cash flow 303.31 n/m 20.82
EV/EBITDA 26.23 n/m 0.64
EV/Sales 4.53 2.46 9.21
Earnings yield (1.82%) (1.22%) (33.15%)
Free cash flow yield 0.33% (2.75%) (25.50%)

Profitability

Metric ANAB IMCR Biotechnology median
Gross margin 100.00% 98.90% 65.16%
Operating margin 17.56% (5.24%) 0.00%
Net margin (11.53%) (4.20%) 0.00%
Free cash flow margin 1.90% (9.55%) 0.00%
Return on equity (114.55%) (4.47%) (56.36%)
Return on assets (7.13%) (1.64%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANAB IMCR Biotechnology median
Revenue growth (TTM) 107.73% 20.95% 6.02%
EPS growth (last fiscal year) 91.02% 30.39% 30.26%
Revenue growth, 5-year CAGR 25.62% 59.57% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANAB IMCR Biotechnology median
Debt to equity 0.00 0.94 0.00
Current ratio 7.58 4.47 4.72
Net debt to EBITDA (6.84) 11.19 0.96

Dividend

Metric ANAB IMCR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANAB IMCR Biotechnology median
Market cap 1.46b 1.52b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack